Supporting lung health with break-through monitoring technology

The University of Adelaide’s Associate Professor David Parsons from the Adelaide Medical School is a leader in cystic fibrosis research.

“Humans take approximately 670 million breaths in their lifetime,” he said.

“Despite this, the tools we currently use when monitoring the lung are in dire need of advancement. For instance, with conditions like cystic fibrosis, early detection of changes in lung function means that a lifetime of complications may be avoided.

“With the current limitations of detection tests such as spirometry and CT scans, early-stage disease in young children often goes undetected, robbing them of a chance at preventative treatments.”

“As XV diagnostics roll out, we stand at the precipice of a new era in lung health measurement.”Associate Professor Martin Donnelley, Adelaide Medical School, University of Adelaide

Fortunately, a significant shift is underway and researchers from the University of Adelaide are working to solve these challenges.

“Our team has helped pioneer the use of X-ray Velocimetry (XV), a technology that allows us not only to capture images of the lung but also to visualise its dynamic movement, assessing lung health with unmatched precision,” said Associate Professor Martin Donnelley, also from the Adelaide Medical School.

“This novel approach, now commercialised by 4DMedical, has paved the way for individualised, targeted treatments and enhanced lung health monitoring.

“As XV diagnostics roll out, we stand at the precipice of a new era in lung health measurement.”

Join Associate Professor Martin Donnelley and Associate Professor David Parsons to learn about this disruptive breakthrough technology, its triumphs, and its promising trajectory.

Speakers

Associate Professor Martin Donnelley is from the Adelaide Medical School at the University of Adelaide. He is the Leader of the Respiratory X-ray Imaging Laboratory and Co-Director of the Cystic Fibrosis Airway Research Group. Martin’s teams focus on X-ray imaging approaches for assessing and tracking airway and lung health, and developing effective airway gene therapies for cystic fibrosis.

Associate Professor David Parsons is Head of the Adelaide Cystic Fibrosis Gene Therapy Group at the Robinson Research Institute, and an Affiliate Senior Lecturer in the Discipline of Paediatrics at the University of Adelaide. He leads the Cystic Fibrosis Stream at the Children's Research Centre and is Chief Medical Scientist in the Department of Respiratory and Sleep Medicine at the Women's and Children's Hospital. David has dedicated 25 years to eradicating cystic fibrosis airway disease and won multiple Service Excellence Awards for his innovations.

The Research Tuesdays lecture series is very popular so early registration to attend the in-person event is advised.
The talk will also be available to watch streamed online.

When

Tuesday, 14 November 2023. 5:30-6:30pm.

Where

The Braggs Building, North Terrace campus, The University of Adelaide

Tickets

Click here to reserve an in-person ticket / Click here to register for the online webinar.